Arkolith/Insider Trading/TCRX/Form 4

Lynx1 Capital Management LP

10% OwnerTScan Therapeutics, Inc. (TCRX) · full profile →Form 4 · filed Jun 2, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$64K
Net Open-Market Flow
-$64K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 31, 2023Sell(S)400$2.51$1K5.2M
May 31, 2023Sell(S)10K$2.51$25K5.2M
May 31, 2023Sell(S)15K$2.52$38K5.2M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000902664-23-003407) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML